Table 3.

Overall risk-adjusted multilevel, multi-effect logistic regression model of all patients to determine independent predictors of inpatient mortality after hepatectomy. P-values in bold are significant predictors.

	OR	95% CI	p-value
Annual surgeon volume (per 10 additional cases/year)	0.94	0.85, 1.05	0.259
Early career surgeon (vs. late)	0.99	0.71, 1.38	0.971
Surgeon Specialization (vs. General Surgeon)
Surgical Oncologist	0.75	0.43, 1.29	0.3
Transplant Surgeon	1.07	0.6, 1.92	0.816
Patient Age (vs. 18-40 years)
41-50 years	1.77	0.78, 4.02	0.172
51-60 years	1.83	0.85, 3.92	0.122
61-70 years	2.65	1.24, 5.63	0.012
71-80 years	3.13	1.41, 6.92	0.005
81-90 years	5.51	2.33,13.01	<0.001
>90 years	16.2	2.78, 94.1	0.002
Female (vs. male)	0.71	0.54, 0.92	0.011
Race (vs. white)
Black	0.97	0.59, 1.58	0.891
Native American	1.8	0.27, 11.9	0.543
Asian	0.98	0.6, 1.6	0.941
Other/Unknown	1.14	0.77, 1.69	0.527
Hispanic (vs. non-hispanic)	1.13	0.67, 1.88	0.652
Charlson Comorbidity Index ≥3 (vs. CCI <3)	1.43	0.95, 2.16	0.088
Insurer (vs. private)
Medicare	1.78	1.24, 2.54	0.002
Medicaid	1.25	0.79, 2.0	0.342
Self-Pay	1.32	0.48, 3.62	0.584
Year (2001–14 vs. 2000)	0.94	0.91, 0.98	0.001
Primary tumor (vs. other indication)	2.21	1.66, 2.95	<0.001
Necrotic liver (vs. non-necrotic)	22.96	15.69, 33.6	<0.001
Biliary reconstruction (vs. no reconstruction)	2.35	1.65, 3.35	<0.001
Lobectomy (vs. wedge)	1.76	1.35, 2.3	<0.001